富罗西米德与辅助阿扎胺与仅在重症患者中的富罗西米德:一个试点两中心随机对照试验
Akinori Maeda1, Alastair Brown2, Sofia Spano3
1Department of Intensive Care, Austin Hospital, Melbourne, Australia; Department of Emergency and Critical Care Medicine, The University of Tokyo, Tokyo, Japan.
Journal of critical care
|December 17, 2024
概括
在重症监护病房中,将乙醇胺添加到furosemide 中,可能会改善尿液反应并预防代谢性. 这项试点研究没有发现严重的安全问题,这表明尿液治疗的潜在益处.
科学领域:
- 临界护理医学 临界护理医学
- 药理学 药理学是指药理学的学科.
- 腎臟病學 (nephrology) 是一種醫學專業.
背景情况:
- 富罗塞米德是重症监护室 (ICU) 中的主要利尿剂.
- 富罗塞米德可以诱导代谢性,这是重症患者常见的酸性干扰.
- 预防富洛塞米德诱导的代谢性病对于患者管理至关重要.
研究的目的:
- 为了评估阿西塔佐拉米德与罗西米德结合的生理效应.
- 评估对利尿和尿液输出的影响.
- 为了确定乙醇胺是否能防止洛胺诱导的代谢性.
主要方法:
- 一个双中心,试点,开放标签,随机化试验进行.
- 重症监护病房的患者接受了罗西米德 (40毫克) 加上阿扎胺 (500毫克) 或单独的罗西米德 (40毫克).
- 尿液输出,酸参数和电解质使用贝叶斯框架进行了比较.
主要成果:
- 在前六小时内,辅助的阿扎胺并没有显著增加尿液输出.
- 乙胺在24小时内维持了对罗胺的更强的尿输出反应 (100%的概率).
- 在6小时内,乙胺酸化血和性尿液,在24小时内没有观察到严重的酸性或电解质干扰.
结论:
- 辅助的阿扎胺可能会增强ICU中的利尿疗效.
- 乙醇胺显示出在平衡furosemide诱导的代谢性中具有潜在的作用.
- 需要进行更大规模的试验来确认这些发现并评估临床结果.
相关概念视频
Heart Failure Drugs: Diuretics
339
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
339
Renal Failure: Dose Adjustments
63
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
63
Dialysis
261
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
261
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
382
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
382
Antihypertensive Drugs: Potassium-Sparing Diuretics
448
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
448
Factors Affecting Renal Clearance: Renal Impairment
53
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
53


